(Q54449535)

English

Etoposide (VP-16) with prednisone and vincristine for the treatment of refractory acute lymphoblastic leukemia.

scientific article published in June 1985

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3859585

retrieved

30 May 2018

reference URL

http://europepmc.org/abstract/MED/3859585

title

Etoposide (VP-16) with prednisone and vincristine for the treatment of refractory acute lymphoblastic leukemia. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3859585

retrieved

30 May 2018

reference URL

http://europepmc.org/abstract/MED/3859585

1 reference

M Abromowitch

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3859585

retrieved

30 May 2018

reference URL

http://europepmc.org/abstract/MED/3859585

W P Bowman

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3859585

retrieved

30 May 2018

reference URL

http://europepmc.org/abstract/MED/3859585

J Ochs

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3859585

retrieved

30 May 2018

reference URL

http://europepmc.org/abstract/MED/3859585

G Rivera

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3859585

retrieved

30 May 2018

reference URL

http://europepmc.org/abstract/MED/3859585

language of work or name

English

0 references

publication date

1 June 1985

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3859585

retrieved

30 May 2018

reference URL

http://europepmc.org/abstract/MED/3859585

published in

Journal of Clinical Oncology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3859585

retrieved

30 May 2018

reference URL

http://europepmc.org/abstract/MED/3859585

volume

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3859585

retrieved

30 May 2018

reference URL

http://europepmc.org/abstract/MED/3859585

issue

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3859585

retrieved

30 May 2018

reference URL

http://europepmc.org/abstract/MED/3859585

page(s)

789-792

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3859585

retrieved

30 May 2018

reference URL

http://europepmc.org/abstract/MED/3859585

Identifiers

DOI

10.1200/JCO.1985.3.6.789

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3859585

retrieved

30 May 2018

reference URL

http://europepmc.org/abstract/MED/3859585

PubMed publication ID

3859585

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3859585

retrieved

30 May 2018

reference URL

http://europepmc.org/abstract/MED/3859585

(Q54449535)

Etoposide (VP-16) with prednisone and vincristine for the treatment of refractory acute lymphoblastic leukemia.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)